dm+d
Unassigned
New Medicines
ZenpepExocrine pancreatic insufficiency in patients with cystic fibrosis (CF)
Information
Zenpep
New formulation
Adare Pharamceuticals
Adare Pharamceuticals
Development and Regulatory status
Discontinued
Discontinued
Launched
May 15. Oral formulation withdrawn for pancreatic disorders in United Kingdom and Belgium [1].
Category
Porcine-derived pancreatic enzyme product consisting of approximately 14 enzymes, coenzymes and cofactors, and is biologically similar to endogenous human pancreatic secretions.
Cystic fibrosis (CF) is a leading cause of exocrine pancreatic insufficiency; around 9,000 people in the UK have CF [2].
Exocrine pancreatic insufficiency in patients with cystic fibrosis (CF)
Oral